Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Micha
J. Micha
Ovarian cancer
Clinical endpoint
Physical therapy
Carboplatin
Paclitaxel
2
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The optically unbiased GRB host (TOUGH) survey. I. Survey design and catalogs 1
2012
Jens Hjorth
Daniele Malesani
Andreas O. Jaunsen
Johan Peter Uldall Fynbo
Javier Gorosabel
Andrew J. Levan
J. Micha
B. Milvang-Jensen
Palle Moller
S. Schulze
Nial R. Tanvir
Show All
Source
Cite
Save
Citations (0)
Phase II multicenter trial of the histone deactylase inhibitor (HDACi) belinostat, carboplatin and paclitaxel (BelCaP) in patients (pts) with relapsed epithelial ovarian cancer (EOC)
2008
Journal of Clinical Oncology
Neil J. Finkler
Don S. Dizon
Patricia S. Braly
J. Micha
Ulrik Lassen
P. Celano
Ros Glasspool
Elizabeth Crowley
P. Buhl-Jensen
Richard T. Penson
Show All
Source
Cite
Save
Citations (11)
1